This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Rosemary T. Berkery net worth and biography

Rosemary Berkery Biography and Net Worth

Director of TJX Companies

Ms. Berkery, age 68, was Chairman of UBS Bank USA and Vice Chairman of UBS Wealth Management Americas, a bank and wealth management firm, from March 2010 until April 2018, also serving as CEO of UBS Bank USA from March 2010 to December 2015. Before joining UBS, she held a variety of roles over more than 25 years at Merrill Lynch & Co., Inc., until her departure in January 2009, including Executive Vice President and General Counsel from 2001 and Vice Chairman from 2007. Ms. Berkery has also been a director of Fluor Corporation since 2010. Ms. Berkery's long career as a senior executive in the financial services industry provides her with expertise in finance, investment strategies, and management of complex global organizations, as well as significant experience in governance, compliance, and risk assessment and oversight.

How do I contact Rosemary T. Berkery?: The corporate mailing address for Ms. Berkery and other TJX Companies executives is 770 Cochituate Road, FRAMINGHAM MA, 01701. TJX Companies can also be reached via phone at (508) 390-1000 and via email at [email protected]. Learn More on Rosemary T. Berkery's contact information.
Has Rosemary T. Berkery been buying or selling shares of TJX Companies?: Rosemary T. Berkery has not been actively trading shares of TJX Companies within the last three months. Most recently, on Friday, May 22nd, Rosemary T. Berkery bought 3,000 shares of TJX Companies stock. The stock was acquired at an average cost of $55.30 per share, with a total value of $165,900.00. Learn More on Rosemary T. Berkery's trading history.
Who are TJX Companies' active insiders?: TJX Companies' insider roster includes Zein Abdalla (Director), Rosemary Berkery (Director), Kenneth Canestrari (EVP), Scott Goldenberg (CFO), Louise Greenlees (Sr. EVP & Group Pres), Louise Greenlees (EVP), Ernie Herrman (CEO), Michael Hines (Director), Amy Lane (Director), Carol Meyrowitz (Chairman), Douglas Mizzi (Sr. EVP & Group Pres ), and Richard Sherr (EVP). Learn More on TJX Companies' active insiders.
Are insiders buying or selling shares of TJX Companies?: In the last year, insiders at the apparel and home fashions retailer sold shares 8 times. They sold a total of 215,886 shares worth more than $19,330,351.87. The most recent insider tranaction occured on March, 21st when CEO Ernie Herrman sold 20,000 shares worth more than $1,979,600.00. Insiders at TJX Companies own 0.1% of the company. Learn More about insider trades at TJX Companies.
Information on this page was last updated on 3/21/2024.

Rosemary T. Berkery Insider Trading History at TJX Companies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/22/2020	Buy	3,000	$55.30	$165,900.00

Rosemary T. Berkery Buying and Selling Activity at TJX Companies

TJX Companies Company Overview

The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer in the United States, Canada, Europe, and Australia. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX International. The company sells family apparel, including footwear and accessories; home fashions, such as home basics, furniture, rugs, lighting products, giftware, soft home products, decorative accessories, tabletop, and cookware, as well as expanded pet, and gourmet food departments; jewelry and accessories; and other merchandise. It offers its products through stores and e-commerce sites. The TJX Companies, Inc. was incorporated in 1962 and is headquartered in Framingham, Massachusetts.

Today's Range

Now: $96.42

$94.47

$97.48

50 Day Range

MA: $97.36

$92.66

$101.42

2 Week Range

Now: $96.42

$75.65

$102.84

Volume

6,248,675 shs

Average Volume

5,075,015 shs

Market Capitalization

$109.24 billion

P/E Ratio

24.98

Dividend Yield

1.41%

Beta

0.86

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad